Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2026-01-29 @ 1:36 PM
Study NCT ID:
NCT04655157
Status:
TERMINATED
Last Update Posted:
2024-05-23
First Post:
2020-12-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma
Sponsor:
Jason J. Luke, MD
Organization: